The Federal Trade Commission has released new data on the last four years’ worth of horizontal merger activity. Analysts saw two major points from these reports: the majority of FTC investigations pertained to mergers that exceeded the threshold for market concentration, determined by the 2010 Horizontal Merger Guidelines; additionally, the FTC treated mergers differently depending on the industry. According to the analysis, there were higher instances of enforcement action within the pharmaceutical and chemical companies, as compared with the hospital, electronically-controlled devides, and branded consumer goods markets.
Featured News
EU’s Largest Economies Push to Reduce Reliance on Foreign Payment Systems
Mar 12, 2026 by
CPI
Warren Presses Amazon for Answers on Pricing Practices for Government Buyers
Mar 12, 2026 by
CPI
EU Antitrust Chief Raises Concerns Over Big Tech Control of AI
Mar 12, 2026 by
CPI
Burson Adds Senior Advisor to Strengthen Competition Team
Mar 12, 2026 by
CPI
South Korea Fines Pork Processors for Price-Fixing in Retail Supply Deals
Mar 12, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece